Page last updated: 2024-08-23

mefloquine and Thyroid Cancer, Anaplastic

mefloquine has been researched along with Thyroid Cancer, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Champa, D; Cuervo, AM; Di Cristofano, A; Orlacchio, A; Patel, B; Ranieri, M; Shemetov, AA; Verkhusha, VV1

Other Studies

1 other study(ies) available for mefloquine and Thyroid Cancer, Anaplastic

ArticleYear
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis.
    Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy-Related Protein 5; Autophagy-Related Protein 7; Cell Proliferation; Enzyme Inhibitors; Humans; Indoles; Lysosomes; Mefloquine; Mice; Mice, Knockout; Necrosis; Proto-Oncogene Proteins c-bcl-2; Pyrroles; RNA Interference; RNA, Small Interfering; Spheroids, Cellular; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Cells, Cultured

2016